Drugs

Researchers recently studied the effect of age on weight loss efforts. The obesity epidemic currently affects over 300 million people around the world. Even developing nations suffer with as many as 115 million people classified as obese. Obesity is related to many other diseases, such as heart disease, high blood pressure, diabetes, stroke, and even
0 Comments
South San Francisco, CA — November 23, 2020 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Xofluza® (baloxavir marboxil) as a treatment to prevent influenza in people 12 years of age and
0 Comments
New research develops vital animal model of SARS-CoV-2 to help identify the key features of infection. The development of effective therapies to treat COVID-19 is a problem of immense global significance. However, one of the key steps in the development of a novel therapeutic is the development of a reliable animal model that can be
0 Comments
FDA Approves Oxlumo (lumasiran) for the Treatment of Primary Hyperoxaluria Type 1 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nov. 24, 2020– Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), the leading RNAi therapeutics company, announced today that the U.S. Food and Drug Administration (FDA) approved Oxlumo (lumasiran) injection for subcutaneous use, the first-ever therapy available for the treatment of primary hyperoxaluria type 1
0 Comments
A recent study demonstrated that Google search trends could help in predicting COVID-19 hot spots.   Web-based activity detection tools can play an important role in the early detection of infectious diseases. These internet search behaviour tools may also help in the timely preparedness of health care systems to avoid the adverse consequences of being
0 Comments
Researchers are investigating the potential of the broad spectrum anti-microbial ivermectin for COVID-19 treatment. As the COVID-19 pandemic, caused by the SARS-CoV-2 virus, continues to spread around the world, researchers are looking for candidate drugs to use as potential therapies. Repurposing drugs already in use for other infections could allow a quicker route to finding
0 Comments
20 November 2020 –  AstraZeneca’s Imfinzi (durvalumab) has been approved in the US for an additional dosing option, a 1,500mg fixed dose every four weeks, in the approved indications of unresectable Stage III non-small cell lung cancer (NSCLC) after chemoradiation therapy (CRT) and previously treated advanced bladder cancer. This new option is consistent with the
0 Comments
November 19, 2020 Audience: Consumer, Patient, Health Professional, Pharmacy November 19, 2020 — Fresenius Kabi USA is voluntarily recalling a single lot of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg/50 mL (4 mcg /mL), 50 mL fill in a 50 mL vial. Fresenius Kabi initiated this recall due to a trace amount of
0 Comments
A new research study detects pre-existing antibody-driven immunity against SARS-CoV-2 in some individuals, with higher rates in uninfected children. Different age groups appear to have different responses to COVID-19, with kids often presenting with mild or no symptoms. However, the reason for this remains relatively unclear.  Although COVID-19 is at the forefront of the news
0 Comments
FDA Approves Zokinvy (lonafarnib) for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies PALO ALTO, Calif., Nov. 20, 2020 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved Zokinvy (lonafarnib) for the
0 Comments
A recent study examined the underlying genetic association between inflammation, metabolic dysregulation, and depressive symptoms. Researchers have been trying to understand what causes mental illness, and how it develops for many decades. In recent years, scientists have been better able to sequences the genomes of people, and look for associations between certain psychological illnesses and
0 Comments
Conservative and natural treatments for pink eye are the most sensible approaches. Conjunctivitis, also known as pink eye, is the inflammation of the eye’s transparent covering caused by viruses, bacteria, pollen, dust, pet dander, smoke and pollutants. Viruses and bacteria are the most frequent suspects in infective conjunctivitis. Viral conjunctivitis is more common than bacterial
0 Comments
Research indicates a possible link between sleep apnea and COVID-19 risk. In the United States, more than 18 million people suffer from sleep apnea, a disorder that makes it difficult to breathe while sleeping. Sleep apnea can lead to poor sleep hygiene and has also been linked to obesity, heart disease, hypertension, and teeth grinding.
0 Comments
vosoritide Treatment for Achondroplasia FDA Accepts BioMarin’s New Drug Application for Vosoritide to Treat Children with Achondroplasia SAN RAFAEL, Calif., Nov. 2, 2020 /PRNewswire/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for vosoritide, an investigational, once daily injection analog of C-type
0 Comments
A recent study reports on the beneficial effects of a new inhalable COVID-19 treatment. Coronavirus disease 19 (COVID-19) originated in Wuhan, China December of 2019 and has since turned into a pandemic. As this rapidly growing health crisis has swept over the globe, it has affected 4 million people and caused 283,000 deaths in over
0 Comments
Treatment for Postoperative Pain Heron Therapeutics Resubmits New Drug Application to FDA for HTX-011 for the Treatment of Postoperative Pain SAN DIEGO, Nov. 13, 2020 /PRNewswire/ – Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced
0 Comments
Natural remedies for sore throats include drinking hot beverages or using salt water, lemon juice, licorice root, marshmallow root, apple cider vinegar, or essential oils. Sore throats are an extremely common health ailment, particularly in the winter. A sore throat can be painful and affect daily life due to swelling and inflammation of cells in
0 Comments
Chronic kidney failure, sometimes referred to as chronic renal failure, describes the loss of kidney function over a period of time. There are five stages, each corresponding with a decreasing level of kidney function, with the last stage called end-stage renal disease. In order to make up for the compromised renal system due to kidney
0 Comments
sutimlimab Treatment for Cold Agglutinin Disease (CAD) FDA Issues Complete Response Letter for Sutimlimab, an Investigational Treatment for Hemolysis in Adults with Cold Agglutinin Disease PARIS – November 13, 2020 - The U.S. Food and Drug Administration issued a Complete Response Letter (CRL) regarding the Biologics License Application (BLA) for sutimlimab, an investigational monoclonal antibody for
0 Comments
KENILWORTH, N.J.–(BUSINESS WIRE) November 13, 2020 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Keytruda, Merck’s anti-PD-1 therapy, in combination with chemotherapy for the treatment of patients with locally recurrent unresectable or metastatic triple-negative breast cancer (TNBC) whose
0 Comments
6 November 2020 — AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of stroke, a leading cause of disability and death worldwide, in patients with acute ischemic stroke (National Institutes of Health Stroke Scale score ≤5) or high-risk transient ischaemic attack (TIA). The approval by the US Food and Drug Administration (FDA)
0 Comments
An established drug – aprotinin – may present a potential treatment for COVID-19. Since the beginning of the SARS-CoV-2 pandemic, medical researchers across the globe have raced to investigate potential treatments for the novel coronavirus. Treatment of the disease using existing drugs has improved in the last six months, reflected by a decrease in the
0 Comments
ibrexafungerp Treatment for Vaginal Candidiasis Scynexis Announces Submission of New Drug Application to the U.S. Food and Drug Administration for Oral Ibrexafungerp for the Treatment of Vaginal Yeast Infection JERSEY CITY, N.J., Oct. 14, 2020 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections,
0 Comments
FDA Approves Sutab (sodium sulfate, magnesium sulfate, and potassium chloride) Tablets for Colonoscopy Preparation BRAINTREE, Mass., Nov. 10, 2020 /PRNewswire/ — Sebela Pharmaceuticals® today announces that the U.S. Food and Drug Administration (FDA) approved Sutab® (sodium sulfate, magnesium sulfate, and potassium chloride) tablets. Sutab, a sulfate-based tablet preparation for colonoscopy, was developed and will be
0 Comments
Clinical trial reports six and a half month longer survival in patients who were treated with new treatment for ALS. Amyotrophic lateral sclerosis or ALS is a progressive nervous system disorder that affects nerve cells in the brain and spinal cord, causing muscle weakness and loss of control. It is also known as Lou Gehrig’s
0 Comments